Daratumumab Plus Carfilzomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
暂无分享，去创建一个
A. Jakubowiak | S. Lonial | A. Oriol | P. Moreau | A. Chari | J. Bladé | B. Arnulf | C. D. de Boer | M. Mateos | J. Martínez-López | L. Benboubker | J. Ukropec | P. Clemens | Jordan M. Schecter | Jianping Wang | P. Rodríguez-Otero | L. Piñeiro | Jordan Schecter